NewDays raises $16M seed round led by Madrona and General Catalyst, expands AI-driven dementia care to Nevada
Seattle startup NewDays closed a $16 million seed round led by Madrona and General Catalyst to scale a telehealth program combining clinicians with an AI companion, Sunny, for treating mild dementia; early research suggests the platform may preserve about 18 months of cognitive function and the service now operates in six states including Nevada.
Seattle Startup NewDays Raises $4.5M to Expand AI Therapy Platform for Mild Dementia Patients
Seattle startup NewDays raised an additional $4.5 million for its generative AI therapy platform that offers telehealth visits and AI-driven cognitive therapies for people with mild dementia. The total funding now stands at $11.5 million to expand its services and advance its AI companion Sunny.
Organizations
-
NewDays Director 2025–present · current